Valuation of the largest companies in the same industry.
Industry median 18.16x
393.44x00030YNBY INTL
20.62x00241ALI HEALTH
18.18x01345SH PIONEER HLDG
18.15x01110KINGWORLD
13.24x00911QIANHAI HEALTH
0x99x198x297x396x
Industry comparison
Distribution of companies by valuation in the industry, with the expected growth of next fiscal year earnings.
Industry median 18.16x
0.00x70.00x140.00x210.00x280.00x350.00x
Current valuation
0.46xP/B
HK$14.80Share price
HK$31.84Book value per share
Valuation history
P/BFair rangeMedian
P/B
0.75x
Fair range
0.68x–0.82x
Peer comparison
Valuation of the largest companies in the same industry.
Industry median 1.31x
5.66x00030YNBY INTL
2.24x00241ALI HEALTH
2.15x01345SH PIONEER HLDG
0.46x01099SINOPHARM
0.35x01110KINGWORLD
0x2x4x6x8x
Industry comparison
Distribution of companies by valuation in the industry, with the expected growth of next fiscal year earnings.
Industry median 1.31x
0.00x1.00x2.00x3.00x4.00x5.00x
Current valuation
0.07xP/S
HK$14.80Share price
HK$213.77Revenue per share
Valuation history
P/SFair rangeMedian
P/S
0.09x
Fair range
0.09x–0.10x
Peer comparison
Valuation of the largest companies in the same industry.
Industry median 0.36x
1.81x01345SH PIONEER HLDG
1.32x00030YNBY INTL
1.17x00241ALI HEALTH
0.36x00574PASHUN INT'L
0.26x01110KINGWORLD
0x1x2x3x4x
Industry comparison
Distribution of companies by valuation in the industry, with the expected growth of next fiscal year earnings.
Industry median 0.36x
0.00x0.40x0.80x1.20x1.60x
Current valuation
5.39%Dividend yield
HK$14.80Share price
HK$0.80Dividend per share
Valuation history
Dividend yieldFair rangeMedian
Dividend yield
4.51%
Fair range
3.94%–4.93%
Peer comparison
Valuation of the largest companies in the same industry.
Industry median 5.39%
7.95%00241ALI HEALTH
5.39%01099SINOPHARM
2.60%01345SH PIONEER HLDG
0x2x4x6x8x
Industry comparison
Distribution of companies by valuation in the industry, with the expected growth of next fiscal year earnings.
Industry median 5.39%
2.00%4.00%6.00%
About this page
This page shows SINOPHARM (01099) on four valuation measures - P/E, P/B, P/S and dividend yield: the current value, the per-share input, 1/3/5/10-year valuation history with its fair range, peer comparison within the same sub-industry, and the industry distribution. Per-share figures come from disclosed statements divided by the shares in issue that month, and each historical point uses the close of that day against the statements published by then.